Lower expression of HLA class I genes as well as of beta-2 microglobulin (β2m) are immune escape mechanisms in NSCLC [122,152,153] and melanoma [153] patients undergoing immune-checkpoint blockade. The gene discussed is B2M; the disease is melanoma.